Ortin Global LimitedQ1 FY27 Results & Financial Update
Ortin Global Limited: Q1 FY27 standalone results and company financials – revenue ₹0.01 Cr, PAT ₹-0.34 Cr. Explore reported YoY/QoQ movements, margins, business drivers and management commentary. This page does not provide a rating, target price or investment recommendation.
Quarter at a glanceReported figures and period changes.Changes compare like-for-like reported periods where available.
Find an answer
Ask this result
Chart · Market context
Ortin Global price & chart
Market price₹15.23
1Y return—Price return
Loading market chart…
TradingView Lightweight Charts™ · Copyright © 2025 TradingView, Inc.TradingView
Market chartPrice chart temporarily unavailableThe price chart could not be loaded right now. The reported financial results remain available above.
Spotted a factual error?Tell us the number, date or statement and we will re-check the underlying records and calculations.Report an error
Quarterly Results AnalysisExplore Ortin Global Q1 FY27 quarterly results and earnings: revenue, profit (PAT), EBITDA, margins, YoY and QoQ growth, order book or business updates where reported, financial performance and management commentary. Reported figures and Nivata calculations are shown separately; no buy, sell or hold recommendation is provided.
Quarter overview
Quarterly earnings analysis
During the quarter ended June 30, 2026, Ortin Global Limited registered modest operational top-line streams alongside persistent bottom-line losses.
Net sales from operations for Q1 FY27 stood at INR 0.0116 crore, while other operating income contributed INR 0.44 crore, bringing total income for the period to INR 0.16 crore.
Total expenses for the quarter amounted to INR 35.06 crore, heavily driven by other expenditures of INR 29.97 crore and employee benefit expenses of INR 4.02 crore.
The substantial cost overheads relative to minimal revenue generation resulted in a pre-tax loss (PBT before exceptional items) of INR 33.46 crore for the quarter.
After accounting for a deferred tax credit adjustment of INR 0.33 crore, the net loss after tax (PAT) for Q1 FY27 widened to INR 33.79 crore.
Basic and diluted earnings per share (EPS) for the quarter stood at a negative INR 0.42, reflecting the ongoing earnings pressure and structural challenges faced by the business during the period.
During the quarter ended 30 June 2026, Ortin Global recorded net sales or income from operations of INR 0.0116 crore along with other operating income of INR 0.044 crore, taking total income to INR 0.016 crore.
01 · Business model
What does Ortin Global do?
Ortin Global Limited (formerly known as Ortin Laboratories Limited) is an Indian corporate entity operating in the pharmaceutical sector, focusing primarily on drugs and medicines.
The company's operations are reported on a standalone basis and are classified under a single operating and reporting segment covering pharmaceutical products.
Ortin manages its registered and administrative operations out of Hyderabad, Telangana, complying with statutory disclosure norms required by Indian stock exchanges.
02 · Financial snapshot
Current quarter vs the two useful baselines
| Metric | Q1 FY27 | Year-ago | Previous quarter |
|---|---|---|---|
| Revenue from operations | ₹0.01 Cr | ₹0.04 Cr | ₹0.03 Cr |
| Total income | ₹0.02 Cr | ₹0.08 Cr | ₹0.31 Cr |
| Profit before tax | ₹-0.33 Cr | ₹-0.16 Cr | ₹-0.01 Cr |
| Profit after tax | ₹-0.34 Cr | ₹-0.18 Cr | ₹-0.01 Cr |
| EPS | ₹-0.42 | ₹-0.22 | ₹-0.01 |
03 · Why it moved
Why the quarter looked the way it did
What drove revenue
Net sales from operations contributed INR 0.0116 crore to the topline during the quarter ended June 30, 2026.
Other operating income added INR 0.44 crore, culminating in a total income of INR 0.16 crore for Q1 FY27.
Net sales from operations contributed INR 0.0116 crore to the total topline during the first quarter of fiscal 2027.
Other operating income added INR 0.044 crore to bring total income for the period to INR 0.016 crore.
What drove margins
Other expenditure formed the largest cost block at INR 29.97 crore, severely compressing margins and driving negative profitability.
Employee benefit expenses stood at INR 4.02 crore, contributing significantly to total quarterly overheads.
Cost of materials consumed was recorded at INR 1.04 crore during the quarter.
Employee benefit costs were reported at INR 4.02 crore for the quarter ended 30 June 2026.
Other expenditures formed the largest cost component at INR 29.97 crore for the quarter.
Material consumption costs stood at INR 1.04 crore during the period.
04 · Segments, products & geography
Which parts of the business are doing the work
Segments and products
The company operates in only one primary business segment, namely Drugs and Medicines, making Ind AS 108 segment reporting not applicable.
The entire operations of the company relate to only one single reportable segment, which is Drugs and Medicines, making Ind AS 108 segment reporting inapplicable.
05 · Pressure points & risks
What is not going smoothly
The company reported a net loss after tax of INR 33.79 crore for Q1 FY27, reflecting severe financial headwinds.
The net loss after tax expanded to INR 33.79 crore for the quarter compared to a net loss of INR 17.54 crore in the corresponding quarter of the previous year.
06 · Cash flow & balance sheet
Profit is one thing. Cash and funding tell another part of the story.
Capital allocation & funding
Finance costs were negligible at practically zero (0.00 crore) for the quarter ended June 30, 2026.
07 · Beyond the numbers
What changed beyond the numbers
Reported update
Statutory Review
The financial results for the quarter ended June 30, 2026, were reviewed by statutory auditors Mathesh & Ramana Chartered Accountants with an unmodified conclusion.
08 · Key Q&A
The quarter, answered directly
What does Ortin Global do?
Ortin Global Limited (formerly known as Ortin Laboratories Limited) is an Indian corporate entity operating in the pharmaceutical sector, focusing primarily on drugs and medicines.
What is the clearest takeaway from Q1 FY27?
During the quarter ended June 30, 2026, Ortin Global Limited registered modest operational top-line streams alongside persistent bottom-line losses.
What drove revenue or demand?
Net sales from operations contributed INR 0.0116 crore to the topline during the quarter ended June 30, 2026.
What mattered most for margins or profitability?
Other expenditure formed the largest cost block at INR 29.97 crore, severely compressing margins and driving negative profitability.
What changed operationally beyond the headline numbers?
The financial results for the quarter ended June 30, 2026, were reviewed by statutory auditors Mathesh & Ramana Chartered Accountants with an unmodified conclusion.
What are the main pressure points disclosed for the quarter?
The company reported a net loss after tax of INR 33.79 crore for Q1 FY27, reflecting severe financial headwinds.
09 · Scenario calculator
Earnings sensitivity: what if growth and margins change?
Starting point
Build your own next-quarter scenario
Reported values are prefilled where a comparable basis is available. Otherwise, the field starts at 0. You can overwrite every field.
Example: enter 10 for 10% revenue growth. Enter -100 for a 1 percentage-point margin decline.
Scenario output
Scenario revenue / income₹0 cr
Scenario profit after tax₹0 cr
Profit change vs base₹0 cr (0%)
Scenario margin0%
Growth needed to keep profit flat after this margin move0%
The calculator holds the selected margin basis constant except for the basis-point adjustment you enter. It does not estimate tax, finance cost, dilution, working capital, valuation or share price.
10 · Next filing checkpoints
What the next disclosure can confirm or change
- 01
Cost Rationalisation: Monitor future disclosures for steps taken by management to control elevated other expenditures and employee costs.
- 02
Topline Recovery: Track upcoming quarterly disclosures to observe whether operational sales from the drugs and medicines segment show meaningful recovery.
- 03
Subsequent Financial Disclosures: Monitor upcoming quarterly financial filings to track the trajectory of operational revenues and expense containment.
Learn the metrics
Need the concepts first?
Use Nivata’s plain-English guides to understand the accounting terms used in this brief before interpreting them.